Webb8 mars 2024 · The IABP-SHOCK II trial (Intra-aortic balloon counterpulsation in patients with AMI-CS; ClinicalTrials.gov identifier: NCT00491036), which compared IABP with medical therapy in patients with AMI-CS, showed that IABP was not associated with any short- or long-term mortality benefit. 34,35 The trial investigators attributed this to the … Webb11 nov. 2024 · The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial …
[PDF] What’s new in cardiogenic shock? Semantic Scholar
WebbThe intra-aortic balloon pump (IABP) is frequently used to support severely compromised ventricles in critically ill patients. Its relatively affordability and ease of insertion has … WebbThiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382(9905):1638-45. reported an elegant, prospective, randomized, multicenter study. dana winner frank galon
A Comprehensive Review of Mechanical Circulatory Support Devices
Webb目的:探讨主动脉内球囊反搏-休克 (IABP-SHOCK)Ⅱ风险评分对国人急性心肌梗死合并心原性休克患者30天死亡率的预测价值.方法:收集2014-06至2024-07在我院因急性心肌梗死合并心原性休克置入主动脉内球囊反搏 (IABP)且行急诊冠状动脉造影的患者212例,根据IABP-SHOCKⅡ风险评分分为0-2分组 (n=106),3-4分组 (n=56)及5-9分组 (n=50).收集患者临 … Webbdeveloping countries such as Indonesia [8]. In several studies on cardiac arrest, IABP have been used with insertion rates of 22% to 46% of phoatients [4]. Nevertheless, the use of IABP is still in debate. Previous multicenter study IABP Shock-II trial found that IABP support does not reduce in hospital mortality in patients with cardiogenic shock Webb図1 IABP-SHOCK II 無作為化比較対照試験における30 日死亡率 急性心筋梗塞に併発した心原性ショック患者を対象としたIABP-SHOCK II無作為化比較対照試験を示す. IABP 留置群は薬物療法(Medical Therapy)群と比し,30 日生存率の有意な改善は認めていない. bird silhouette to scare birds